Health Canada drug identification number

DIN 02308215 — RELISTOR 20 MG

RELISTOR is a solution of Methylnaltrexone marketed by SALIX PHARMACEUTICALS INC. The full Methylnaltrexone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02308215
Brand name
RELISTOR
Active ingredient
Methylnaltrexone
Strength
20 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
SALIX PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Peripherally acting mu-opioid receptor antagonist (PAMORA)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.